Philips has inked a research agreement with Memorial Sloan Kettering and a precision medicine deal with Illumina and Navican.
Data from Dexcom’s continuous glucose monitors can now be synced with Glooko’s diabetes management platform via the cloud rather than through a cable.
Neoantigen-based cancer vaccines represent new, truly personalized therapeutic approaches to treating cancer.
Grail, which seeks to develop liquid biopsies to catch cancer early, has agreed to merge with Hong Kong-based Cirina.
Saluda Medical has raised $40 million in a round led by a GSK's bioelectronic medicine VC fund.
How PAREXEL's New Ecosystem of Technology, Processes and Expertise is Transforming Drug Development
Seegene has joined with Thermo Fisher Scientific to bring its diagnostic assays to market in the U.S.
MAP Health Management is tapping IBM Watson’s cognitive computing tools to enhance its behavioral health management technology.
Olympus and the Colon Cancer Coalition are partnering on a public education and awareness scheme with the goal of raising the screening rate for colon cancer.
Senseonics is joining with diabetes management company TypeZero to develop an artificial pancreas system based on its implantable continuous glucose monitor.
LivaNova will acquire Caisson Interventional, a Minnesota-based heart valve maker, for $72 million.
Theranos settled two lawsuits with Partner Fund Management, which backed the embattled blood-testing startup with a $96.1 million investment in 2014.